Ovarian cancer proteomic landscape changes across different pathological stages and biomarker-sets identified with integrative multiomics analysis.

Wang Y, Fang Z, Xu N, Chen L, Zhan X

Open source

DOI
10.3389/fendo.2026.1898210
Published
2026
Container
Frontiers in endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fendo.2026.1898210,
  title = {Ovarian cancer proteomic landscape changes across different pathological stages and biomarker-sets identified with integrative multiomics analysis.},
  author = {Wang Y and Fang Z and Xu N and Chen L and Zhan X},
  year = {2026},
  journal = {Frontiers in endocrinology},
  doi = {10.3389/fendo.2026.1898210},
  url = {https://doi.org/10.3389/fendo.2026.1898210}
}

RIS

TY  - JOUR
TI  - Ovarian cancer proteomic landscape changes across different pathological stages and biomarker-sets identified with integrative multiomics analysis.
AU  - Wang Y
AU  - Fang Z
AU  - Xu N
AU  - Chen L
AU  - Zhan X
PY  - 2026
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1898210
UR  - https://doi.org/10.3389/fendo.2026.1898210
ER  - 

APA

Y, W., Z, F., N, X., L, C., & X, Z. (2026). Ovarian cancer proteomic landscape changes across different pathological stages and biomarker-sets identified with integrative multiomics analysis.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1898210

Source records